This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.
The current price of LOBEF is $0.06 USD — it has decreased by -6% in the past 24 hours. Watch Lobe Sciences stock price performance more closely on the chart.
What is Lobe Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lobe Sciences stocks are traded under the ticker LOBEF.
Is Lobe Sciences stock price growing?▼
LOBEF stock has fallen by -3.33% compared to the previous week, the month change is a +954.55% rise, over the last year Lobe Sciences has showed a +1,712.5% increase.
What is Lobe Sciences market cap?▼
Today Lobe Sciences has the market capitalization of 15.63M
What is Lobe Sciences revenue for the last year?▼
Lobe Sciences revenue for the last year amounts to 0 USD.
What is Lobe Sciences net income for the last year?▼
LOBEF net income for the last year is -3.2M USD.
In which sector is Lobe Sciences located?▼
Lobe Sciences operates in the Health & Wellness sector.
When did Lobe Sciences complete a stock split?▼
The last stock split for Lobe Sciences was on June 10, 2022 with a ratio of 1:6.
Where is Lobe Sciences headquartered?▼
Lobe Sciences is headquartered in Vancouver, Canada.